• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.

作者信息

Lauten Melchior, Asgedom Girmay, Welte Karl, Schrappe Martin, Stanulla Martin

出版信息

Haematologica. 2003 Mar;88(3):353-4.

PMID:12651279
Abstract
摘要

相似文献

1
Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.胸苷酸合成酶基因多态性及其与儿童B细胞前体急性淋巴细胞白血病复发的关联。
Haematologica. 2003 Mar;88(3):353-4.
2
Polymorphism of the thymidylate synthase gene and risk of relapse in childhood ALL.胸苷酸合成酶基因多态性与儿童 ALL 复发风险。
Leuk Res. 2011 Nov;35(11):1464-6. doi: 10.1016/j.leukres.2011.04.007. Epub 2011 May 7.
3
Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.谷胱甘肽S-转移酶基因缺失对儿童B前体急性淋巴细胞白血病早期复发的影响
Haematologica. 2003 Nov;88(11):1238-44.
4
Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.微小残留病值可区分21号染色体存在染色体内扩增的B细胞前体急性淋巴细胞白血病患儿的低复发风险和高复发风险：奥地利及德国急性淋巴细胞白血病柏林-法兰克福-明斯特（ALL-BFM）试验
J Clin Oncol. 2008 Jun 20;26(18):3046-50. doi: 10.1200/JCO.2008.16.1117.
5
Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population.胸苷酸合成酶增强子区域多态性与克什米尔人群急性淋巴细胞白血病易感性无关。
Genet Mol Res. 2012 Apr 10;11(2):906-17. doi: 10.4238/2012.April.10.6.
6
Translocation (1;13)(p34;q32) in childhood pre-B-cell acute lymphoblastic leukemia.儿童前B细胞急性淋巴细胞白血病中的易位（1；13）（p34；q32）
Cancer Genet Cytogenet. 2000 Aug;121(1):107-8.
7
Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.印度尼西亚白血病患儿与非白血病患儿的亚甲基四氢叶酸还原酶（MTHFR）C677T多态性和胸苷酸合成酶启动子（TSER）多态性
Leuk Res. 2008 Jan;32(1):19-24. doi: 10.1016/j.leukres.2007.02.011. Epub 2007 Mar 28.
8
[Genetic analysis of changes in sizes of telomeres and anti-oncogenes p53 and Rb in children with pre-B acute lymphoblastic leukemia].
Biull Eksp Biol Med. 1999 Apr;127(4):439-41.
9
Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis.
Pharmacogenomics J. 2005;5(6):374-80. doi: 10.1038/sj.tpj.6500332.
10
CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.CDKN2基因缺失在儿童前体B淋巴细胞急性淋巴细胞白血病中无预后价值。
Leukemia. 2005 Jul;19(7):1281-4. doi: 10.1038/sj.leu.2403769.

引用本文的文献

1
The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.药物基因组学在降低急性淋巴细胞白血病维持治疗期间毒性方面的前景。
Genomics Proteomics Bioinformatics. 2017 Apr;15(2):82-93. doi: 10.1016/j.gpb.2016.11.003. Epub 2017 Apr 6.
2
Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia.叶酸相关基因多态性对土耳其急性淋巴细胞白血病儿童大剂量甲氨蝶呤相关毒性及预后的影响
Turk J Haematol. 2017 Jun 5;34(2):143-150. doi: 10.4274/tjh.2016.0007. Epub 2016 Apr 18.
3
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy.
药物遗传学对急性淋巴细胞白血病治疗中反应和毒性的预测作用
Blood Rev. 2015 Jul;29(4):243-9. doi: 10.1016/j.blre.2015.01.001. Epub 2015 Jan 10.
4
Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?白种人和越南儿童急性淋巴细胞白血病风险多态性的比较药物遗传学分析：治疗结果的预测？
Br J Clin Pharmacol. 2015 Mar;79(3):429-40. doi: 10.1111/bcp.12481.
5
Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?甲氨蝶呤在急性淋巴细胞白血病中的药物遗传学：为何仍停留在实验阶段？
Eur J Clin Pharmacol. 2014 Mar;70(3):253-60. doi: 10.1007/s00228-013-1623-4. Epub 2013 Dec 27.
6
Thymidylate synthase and methionine synthase polymorphisms are not associated with susceptibility to childhood acute lymphoblastic leukemia in Kurdish population from Western Iran.胸苷酸合成酶和蛋氨酸合成酶多态性与伊朗西部库尔德人群儿童急性淋巴细胞白血病易感性无关。
Mol Biol Rep. 2012 Mar;39(3):2195-200. doi: 10.1007/s11033-011-0968-y. Epub 2011 Jun 5.
7
PharmGKB summary: methotrexate pathway.药物基因组学知识库摘要：甲氨蝶呤途径。
Pharmacogenet Genomics. 2011 Oct;21(10):679-86. doi: 10.1097/FPC.0b013e328343dd93.
8
Pharmacogenetics in acute lymphoblastic leukemia.急性淋巴细胞白血病中的药物遗传学
Semin Hematol. 2009 Jan;46(1):39-51. doi: 10.1053/j.seminhematol.2008.09.002.
9
Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.急性淋巴细胞白血病患儿预后的药物遗传学
Blood. 2005 Jun 15;105(12):4752-8. doi: 10.1182/blood-2004-11-4544. Epub 2005 Feb 15.